105 related articles for article (PubMed ID: 7836430)
21. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes.
Ursø B; Cope DL; Kalloo-Hosein HE; Hayward AC; Whitehead JP; O'Rahilly S; Siddle K
J Biol Chem; 1999 Oct; 274(43):30864-73. PubMed ID: 10521479
[TBL] [Abstract][Full Text] [Related]
22. Insulin and insulin-like growth factor-I signal transduction requires p21ras.
Jhun BH; Meinkoth JL; Leitner JW; Draznin B; Olefsky JM
J Biol Chem; 1994 Feb; 269(8):5699-704. PubMed ID: 8119907
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human alpha 2-HS glycoprotein inhibits insulin-stimulated mitogenic pathway without affecting metabolic signalling in Chinese hamster ovary cells overexpressing the human insulin receptor.
Srinivas PR; Deutsch DD; Mathews ST; Goustin AS; Leon MA; Grunberger G
Cell Signal; 1996 Dec; 8(8):567-73. PubMed ID: 9115849
[TBL] [Abstract][Full Text] [Related]
24. Reduced phosphorylation of mitogen-activated protein kinase kinase in response to insulin in cells with truncated C-terminal domain of insulin receptor.
Carel K; DePaolo D; Reusch JE; Leitner JW; Draznin B
Endocrinology; 1996 Jun; 137(6):2362-6. PubMed ID: 8641187
[TBL] [Abstract][Full Text] [Related]
25. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation.
Sasaoka T; Draznin B; Leitner JW; Langlois WJ; Olefsky JM
J Biol Chem; 1994 Apr; 269(14):10734-8. PubMed ID: 8144662
[TBL] [Abstract][Full Text] [Related]
26. Evidence that p21ras mediates the neurotrophic effects of insulin and insulin-like growth factor I in chick forebrain neurons.
Robinson LJ; Leitner W; Draznin B; Heidenreich KA
Endocrinology; 1994 Dec; 135(6):2568-73. PubMed ID: 7988444
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of palmitate on glucose uptake in rat-1 fibroblasts and 3T3-L1 adipocytes.
Usui I; Haruta T; Takata Y; Iwata M; Uno T; Takano A; Ueno E; Ishibashi O; Ishihara H; Wada T; Sasaoka T; Kobayashi M
Horm Metab Res; 1999 Oct; 31(10):546-52. PubMed ID: 10596963
[TBL] [Abstract][Full Text] [Related]
28. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes.
Genot E; Reif K; Beach S; Kramer I; Cantrell D
Oncogene; 1998 Oct; 17(13):1731-8. PubMed ID: 9796702
[TBL] [Abstract][Full Text] [Related]
29. Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis.
Müller C; Bockhorn AG; Klusmeier S; Kiehl M; Roeder C; Kalthoff H; Koch OM
Int J Oncol; 1998 Mar; 12(3):717-23. PubMed ID: 9472115
[TBL] [Abstract][Full Text] [Related]
30. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
Rao YP; Buckley DJ; Buckley AR
Cell Growth Differ; 1995 Oct; 6(10):1235-44. PubMed ID: 8845300
[TBL] [Abstract][Full Text] [Related]
31. Arachidonic acid mediates angiotensin II effects on p21ras in renal proximal tubular cells via the tyrosine kinase-Shc-Grb2-Sos pathway.
Jiao H; Cui XL; Torti M; Chang CH; Alexander LD; Lapetina EG; Douglas JG
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7417-21. PubMed ID: 9636164
[TBL] [Abstract][Full Text] [Related]
32. Shc associates with an unphosphorylated form of the p21ras guanine nucleotide exchange factor mSOS.
de Vries-Smits AM; Pronk GJ; Medema JP; Burgering BM; Bos JL
Oncogene; 1995 Mar; 10(5):919-25. PubMed ID: 7898933
[TBL] [Abstract][Full Text] [Related]
33. Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice.
Sebti SM; Tkalcevic GT; Jani JP
Cancer Commun; 1991 May; 3(5):141-7. PubMed ID: 2043425
[TBL] [Abstract][Full Text] [Related]
34. Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression.
Medema RH; Wubbolts R; Bos JL
Mol Cell Biol; 1991 Dec; 11(12):5963-7. PubMed ID: 1658621
[TBL] [Abstract][Full Text] [Related]
35. Complex formation between the p21ras GTPase-activating protein and phosphoproteins p62 and p190 is independent of p21ras signalling.
Pronk GJ; de Vries-Smits AM; Ellis C; Bos JL
Oncogene; 1993 Oct; 8(10):2773-80. PubMed ID: 8378086
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action.
Sharma PM; Egawa K; Huang Y; Martin JL; Huvar I; Boss GR; Olefsky JM
J Biol Chem; 1998 Jul; 273(29):18528-37. PubMed ID: 9660823
[TBL] [Abstract][Full Text] [Related]
37. ras isoprenylation is required for ras-induced but not for NGF-induced neuronal differentiation of PC12 cells.
Qiu MS; Pitts AF; Winters TR; Green SH
J Cell Biol; 1991 Nov; 115(3):795-808. PubMed ID: 1918164
[TBL] [Abstract][Full Text] [Related]
38. Expression of a catalytically inert Syp blocks activation of MAP kinase pathway downstream of p21ras.
Sawada T; Milarski KL; Saltiel AR
Biochem Biophys Res Commun; 1995 Sep; 214(2):737-43. PubMed ID: 7677789
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells.
Oliveira CJ; Schindler F; Ventura AM; Morais MS; Arai RJ; Debbas V; Stern A; Monteiro HP
Free Radic Biol Med; 2003 Aug; 35(4):381-96. PubMed ID: 12899940
[TBL] [Abstract][Full Text] [Related]
40. Contrasting signaling pathways of alpha1A- and alpha1B-adrenergic receptor subtype activation of phosphatidylinositol 3-kinase and Ras in transfected NIH3T3 cells.
Hu ZW; Shi XY; Lin RZ; Hoffman BB
Mol Endocrinol; 1999 Jan; 13(1):3-14. PubMed ID: 9892008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
